ArticleTherapeutic advances in medical oncology2020

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy.

Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.